The Valley Desk

NCT03602859 · Interventional trial

A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer

Overall registry status Active not recruiting

Phase 3

Conditions Ovarian Neoplasms, Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov